Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    -0.0025 (-0.76%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Joint Development and Supply Agreement

7 Apr 2016 07:00

RNS Number : 4341U
Haydale Graphene Industries PLC
07 April 2016
 

 

Haydale Graphene Industries plc

 

("Haydale" or the "Group")

 

Joint Development and Supply Agreement for the Production of screen printable ink aimed at the sensor market.

 

 

Haydale Graphene Industries plc (AIM: HAYD), the Group focused on enabling technology for the commercialisation of graphene and other nano materials, is pleased to announce an agreement with Taiwan based Dowton Electronic Materials Co., Ltd., ("Dowton") for the development, production, sales and marketing of a Haydale-branded graphene enhanced screen printable ink which will be aimed initially at the biomedical market ("the Agreement").

 

The Agreement

 

Haydale has worked with Dowton to create a range of graphene enhanced screen printable inks and pastes that can be rapidly altered to precisely suit customer needs. In the Agreement, Haydale will retain the exclusive rights to sell the developed inks into Europe, the Americas, Korea and Southeast Asia, whilst Dowton will have exclusive rights to sell the developed inks in their home market of The Republic of China (Taiwan) and also market the ink to existing customers in Japan and other territories. Dowton has existing customer demand for conductive inks incorporating both carbon and metals (such as Palladium, Silver Copper, and Nickel), and will continue to sell existing products under its own Dowton brand.

 

The Agreement is for an initial term of 5 years with automatic renewal thereafter subject to a 6 months termination clause. Production quantities for commercial applications are anticipated in 2016 with leads already under evaluation.

 

Commenting, Ray Gibbs Haydale CEO said:

 

"Working with Dowton has been enlightening in that they get things completed quickly with minimum fuss. Their technical expertise is outstanding along with production facilities and equipment. They have helped us to, quickly, produce an excellent base conductive ink (or as they describe it a paste) that has been built on our existing product. The developed paste is specifically designed for the screen printing of bio medical sensors, which is a substantial market, especially in the Far East. Even after 15 years of industry experience Dowton has expressed to us how surprised they were with the superior performance of our graphene based paste and have stated they have customers ready to trial the product. We therefore anticipate revenues from this Agreement during 2016.

 

Mr Hsu Shen-An, the Dowton CEO added:

 

"Working with Haydale has been surprisingly easy and the quality of the graphene pastes we have tested are simply some of the best performing we have seen, especially for conductivity and stability of performance, which is crucial for repeat sales. We are very excited by Haydale's graphene paste and have expectations of strong interest from our existing customer in the bio medical sensor market."

 

 

For further information please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

Emma Earl

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman (Corporate Finance)

Will Goode (Corporate Finance)

Hermes Financial PR

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

 

About Haydale

Haydale has developed a patented scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost-efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a patented low-pressure plasma process that treats both mined, organic fine powder and other synthetically produced nanomaterial powders, producing high-quality few layered graphenes and graphene nanoplatelets. The process can functionalise with a range of chemical groups, with the level of functionalisation tailored to the customer's needs. Good dispersion improves the properties and performance of the host material and ensures the final product performs as specified.

The Haydale plasma process does not use wet chemistry, nor does it damage the material being processed; rather, it can clean up any impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale process is a patented enabling technology, allowing the Group to work with a raw material producer who seeks to add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales and housed in a purpose-built facility for processing and handling nanomaterials, is facilitating the application of graphenes and other nanomaterials in fields such as inks, sensors, energy storage, composites, paints and coatings.

www.haydale.com Twitter: @haydalegraphene

 

 

About Dowton

 

Dowton was established in 2000 and is based in Kaohsiung, Taiwan. Its main business is as a material supplier to the billion dollar Multi-Layer Chip Capacitor ("MLCC") market for Taiwanese and tier 1 manufacturers in the world. They offer high quality ink/paste products and total flexibility enabling rapid supply of customized products and a fully functioning customer support centre. Their product lines include special printable materials for MLCC, touch panel, thick film, thermal materials and biosensor markets. Dowton have ISO9001 accreditation through the BSI in 2008 and a 1,000 level clean room with temperature, humidity and positive pressure controls. Other ink and paste making facilities include state of the art dispersion equipment. In addition Dowton has a nano ceramics additive capability.

The speciality pastes sold by Dowton include Palladium, Silver, Copper and Nickel.

Their overall production capacity is 80,000kgs of pastes per month

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRUGUACCUPQPGQ
Date   Source Headline
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.